Skip to content
Independent analysis of NHS open data
PharmaInsight

Co-codaprin (Codeine phosphate/aspirin)

Central Nervous System Analgesics BNF 0407010M0
Data updated March 2024 Download CSV
1items

Dispensed in March 2024

0items

Rolling 12 months

£0

Net ingredient cost · March 2024

Figure 1. Co-codaprin (Codeine phosphate/aspirin): national items dispensed by month

0 1 2 Feb 2021 Jun 2022 Oct 2022 Jan 2023 Mar 2024 1 Feb 2021: 1 Nov 2021: 1 Jun 2022: 1 Jul 2022: 1 Oct 2022: 2 Dec 2022: 1 Jan 2023: 2 Apr 2023: 1 Aug 2023: 1 Mar 2024: 1

Source: NHSBSA Prescription Cost Analysis, to March 2024

Download CSV
Embed this chart

At a glance

  • Therapeutic class Analgesics
  • Presentations 1 shown
  • Average cost / item £0.34
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, March 2024

The individual products dispensed under Co-codaprin (Codeine phosphate/aspirin) this month.

Presentations of Co-codaprin (Codeine phosphate/aspirin), March 2024
Presentation BNF code Items Net ingredient cost
Boots Aspirin and Codeine tablets 0407010M0BCAAAA 1 £0

Source: NHSBSA Prescription Cost Analysis · to March 2024 OGL v3.0

Where Co-codaprin (Codeine phosphate/aspirin) is dispensed

The regions and dispensing practices with the highest Co-codaprin (Codeine phosphate/aspirin) volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Co-codaprin (Codeine phosphate/aspirin) with

Other medicines in the same BNF section, by prescribing volume.